Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | ||
Founding Date | Founding Date 2014 | Founding Date 2016 |
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations Oxford, GB HQ Dublin, IE Burlington, US | Locations Tucson, US HQ |
Employees | Employees 1061% decrease | Employees 1220% increase |
Funding | ||
Total funding raised | Total funding raised $ 19.7m | Total funding raised $ 1.6m |
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company